February 2019
-
02.12.2019 Partnerships G-CON Manufacturing Delivers New PCMM POD® With Tablet Coating Capability to Pfizer Inc.’s Groton, Conn. Site
January 2019
-
01.09.2019 Partnerships eFFECTOR Enters Into Agreement with Pfizer Inc. to Develop Novel First-inClass Inhibitors of eIF4E to Treat Multiple Cancer Types -
01.07.2019 Partnerships CytoReason Signs Collaboration Agreement with Pfizer Inc. To Utilize CytoReason’s Machine Learning Model of the Immune System for Drug Discovery
December 2018
-
12.17.2018 Partnerships Kineta Enters Research Collaboration and License Agreement with Pfizer to Develop New Cancer Immunotherapies
October 2018
-
10.25.2018 Partnerships CANCER THERAPEUTICS CRC SIGNS AGREEMENT TO ENABLE PFIZER TO DEVELOP NOVEL CANCER DRUGS
September 2018
-
09.17.2018 Partnerships ATOMWISE ENTERS INTO AN EVALUATION AGREEMENT WITH PFIZER -
09.12.2018 Partnerships System1 Announces a $25 Million Series A Funding to Advance Integrated Technology Platform for Neurotherapeutics Discovery -
09.06.2018 Partnerships CYTOO enters into Research and Option Agreement with Pfizer to develop a target discovery platform for Duchenne Muscular Dystrophy -
09.05.2018 Partnerships 4D Molecular Therapeutics Raises $90 Million Series B Financing
August 2018
-
08.16.2018 Partnerships BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza -
08.08.2018 Partnerships SANGAMO ANNOUNCES POSITIVE PRELIMINARY DATA FROM THE PHASE 1/2 ALTA STUDY EVALUATING SB-525 GENE THERAPY FOR HEMOPHILIA A
July 2018
-
07.03.2018 Partnerships RESOLUTE:13 academic & industry partners join forces to unlock SLCs for new therapies